H. Weiss

J. Kolesar, H. Weiss, S. Arnold, 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Tissue-Specific Downregulation of Fatty Acid Synthase Suppresses Intestinal Adenoma Formation via Coordinated Reprograming of Transcriptome and Metabolism in the Mouse Model of Apc-Driven Colorectal Cancer

Chi Wang, Jinpeng Liu, H. Weiss, 2022, International journal of molecular sciences.

Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers.

D. Heimburger, H. Weiss, U. Manne, 2003, Chest.

Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.

H. Weiss, U. Manne, W. Grizzle, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer.

L. Freedman, G. Kelloff, K. Cronin, 2001, Urology.

The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON.

H. Weiss, Eun Y. Lee, B. Evers, 2011, Anticancer research.

Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer

H. Weiss, Eun Y. Lee, B. Evers, 2020, Cells.

Profiles of Radioresistance Mechanisms in Prostate Cancer.

H. Weiss, N. Kyprianou, D. S. Clair, 2018, Critical reviews in oncogenesis.

Differential Abundance Analysis with Bayes Shrinkage Estimation of Variance (DASEV) for Zero-Inflated Proteomic and Metabolomic Data

Xiangrong Yin, A. Lane, R. Higashi, 2020, Scientific Reports.

Ketogenesis alleviates TNFα-induced apoptosis and inflammatory responses in intestinal cells.

H. Weiss, Jinhwan Kim, B. Evers, 2021, Free radical biology & medicine.

Neurotensin differentially regulates bile acid metabolism and intestinal FXR‐bile acid transporter axis in response to nutrient abundance

H. Weiss, B. Evers, L. T. Weiss, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Ketogenesis contributes to intestinal cell differentiation

A. Lane, H. Weiss, T. Fan, 2016, Cell Death and Differentiation.

The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial.

Katherine C. Sexton, J. Bacus, H. Weiss, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

The VR-DCEP regimen rescues mobilization failures and controls refractory disease in multiple myeloma

M. Krem, H. Weiss, S. Reynolds, 2019, Bone Marrow Transplantation.

Ketogenesis attenuates KLF5-dependent production of CXCL12 to overcome the immunosuppressive tumor microenvironment in colorectal cancer.

Chi Wang, Jinpeng Liu, H. Weiss, 2022, Cancer research.

E1A‐F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase‐2 and matrix metalloproteinase‐7

K. Bland, R. Diasio, H. Weiss, 2005, Molecular carcinogenesis.

Phase II trial design with growth modulation index as the primary endpoint

J. Villano, H. Weiss, Jianrong Wu, 2018, Pharmaceutical statistics.

Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease.

H. Weiss, V. Resto, Yimei Han, 2010, Journal of experimental therapeutics & oncology.

High plasma levels of pro-NT are associated with increased colon cancer risk.

H. Weiss, L. Donato, B. Evers, 2020, Endocrine-related cancer.

Androgenic regulation of growth factor and growth factor receptor expression in the cwr22 model of prostatic adenocarcinoma

H. Weiss, U. Manne, W. Grizzle, 1999, International Journal of Cancer.

Regulation of SIRT2 by Wnt/β-catenin signaling pathway in colorectal cancer cells.

H. Weiss, Yuning Zhou, B. Evers, 2021, Biochimica et biophysica acta. Molecular cell research.

Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors

V. Rangnekar, J. Villano, H. Weiss, 2018, Genes & cancer.

FFAR4 Is Involved in Regulation of Neurotensin Release From Neuroendocrine Cells and Male C57BL/6 Mice

H. Weiss, B. Evers, C. Townsend, 2018, Endocrinology.

Integrin α6β4 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin

H. Weiss, J. D'Orazio, Min Chen, 2022, Frontiers in Oncology.

Dihydropyrimidine dehydrogenase (DPD) rapidly regenerates after inactivation by eniluracil (GW776C85) in primary and metastatic colorectal cancer

R. Diasio, H. Weiss, V. Lucas, 2003, Cancer Chemotherapy and Pharmacology.

p53 and erbB-2 Are Not Associated in Matched Cases of Primary and Metastatic Ovarian Carcinomas

H. Weiss, W. Grizzle, E. Partridge, 2004, Disease markers.

Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia.

D. Bostwick, R. Poczatek, H. Weiss, 1999, The Journal of urology.

Apoptosis induction by the core biopsy procedure.

Jenny C. Chang, H. Weiss, S. Mohsin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase 1, Pharmacokinetic and Pharmacodynamic Study of Temozolomide in Pediatric Patients with Refractory/Recurrent Leukemia: A Children’s Oncology Group Study

Ingle, P. Adamson, H. Weiss, 2019 .

Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.

P. Adamson, H. Weiss, T. Horton, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer.

Chi Wang, H. Weiss, E. Romond, 2014, Future oncology.

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

Hong Zhao, Jenny C. Chang, W. Qian, 2015, Breast Cancer Research.

Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma.

T. Pretlow, H. Weiss, U. Manne, 1999, The Journal of urology.

Prognostic significance of Bcl‐2 expression and p53 nuclear accumulation in colorectal adenocarcinoma

R. Poczatek, H. Weiss, U. Manne, 1997, International journal of cancer.

Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery.

Tonglei Li, Richard A Gemeinhart, H. Weiss, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Therapeutics , Targets , and Chemical Biology InhibitionofFattyAcidSynthaseAttenuatesCD 44-Associated Signaling and Reduces Metastasis in Colorectal Cancer

W. Mustain, H. Weiss, Eun Y. Lee, 2012 .

InhibitionofFattyAcidSynthaseAttenuatesCD 44-Associated Signaling and Reduces Metastasis in Colorectal Cancer

W. Mustain, H. Weiss, Eun Y. Lee, 2012 .

Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre‐ and postmenopausal women

H. Weiss, W. Grizzle, A. Frost, 2002, International journal of cancer.

Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.

Sara M. Johnson, B. Rampy, H. Weiss, 2010, Journal of the American College of Surgeons.

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

R. Schiff, C. Osborne, H. Weiss, 2004, Journal of the National Cancer Institute.

Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer

Mihail I Mitov, H. Weiss, M. Mitov, 2017, Cell Death & Disease.

Ketogenesis contributes to intestinal cell differentiation

H. Weiss, T. Fan, Yuning Zhou, 2016, Cell Death & Differentiation.

Cancer 2-2018 Neurotensin Receptor 3 / Sortilin Contributes to Tumorigenesis of Neuroendocrine Tumors Through Augmentation of Cell Adhesion and Migration

H. Weiss, B. Evers, Eun Y. Lee, 2019 .

Neurotensin Receptor 3/Sortilin Contributes to Tumorigenesis of Neuroendocrine Tumors Through Augmentation of Cell Adhesion and Migration1

H. Weiss, B. Evers, Eun Y. Lee, 2017, Neoplasia.

Integrin α6β4 signaling switches DNA repair from homologous recombination to non-homologous end-joining pathway to sensitize breast cancer cells to cisplatin

S. Jarrett, H. Weiss, J. D'Orazio, 2019, bioRxiv.

Nuclear factor of activated T-cells 5 increases intestinal goblet cell differentiation through an mTOR/Notch signaling pathway

H. Weiss, Yuning Zhou, B. Evers, 2014, Molecular biology of the cell.

NFAT5 represses canonical Wnt signaling via inhibition of β-catenin acetylation and participates in regulating intestinal cell differentiation

H. Weiss, Y. Zhou, B. Evers, 2013, Cell Death and Disease.

Nuclear factor of activated T-cell c3 inhibition of mammalian target of rapamycin signaling through induction of regulated in development and DNA damage response 1 in human intestinal cells

H. Weiss, Zheng Guo, Yuning Zhou, 2012, Molecular biology of the cell.

An obligatory role for neurotensin in high fat diet-induced obesity

O. Melander, P. Nilsson, M. Orho-Melander, 2016, Nature.

Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells

H. Weiss, B. Evers, Ji Tae Kim, 2017, International journal of oncology.

Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells

H. Weiss, B. Evers, Eun Y. Lee, 2015, Oncotarget.

Neurotensin, a novel target of Wnt/β‐catenin pathway, promotes growth of neuroendocrine tumor cells

H. Weiss, B. Evers, Chunming Liu, 2015, International journal of cancer.

Nrbf2 Protein Suppresses Autophagy by Modulating Atg14L Protein-containing Beclin 1-Vps34 Complex Architecture and Reducing Intracellular Phosphatidylinositol-3 Phosphate Levels*

Deanna H. Morris, Qing Jun Wang, Brian T Chait, 2014, The Journal of Biological Chemistry.

Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells

Chi Wang, H. Weiss, Eun Y. Lee, 2020, Frontiers in Oncology.

Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells

S. Fuqua, I. Barone, S. Andò, 2011, Clinical Cancer Research.

Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells

H. Weiss, Yuning Zhou, B. Evers, 2019, Cells.

Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA.

S. Shirasawa, T. Sasazuki, H. Weiss, 2012, Carcinogenesis.

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.

H. Weiss, Eun Y. Lee, B. Evers, 2011, Cancer research.

Molecular and Cellular Pathobiology mTORC 1 and mTORC 2 Regulate EMT , Motility , and Metastasis of Colorectal Cancer via RhoA and Rac 1 Signaling Pathways

H. Weiss, Eun Y. Lee, B. Evers, 2011 .

Erbin Suppresses KSR1-Mediated RAS/RAF Signaling and Tumorigenesis in Colorectal Cancer.

Chi Wang, M. Inagaki, H. Weiss, 2018, Cancer research.

Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer

H. Weiss, T. O’Halloran, Pallavi Sethi, 2016, Oncotarget.

Impact of post-radiation biopsies on development of fistulae in patients with cervical cancer.

H. Weiss, C. Desimone, J. Feddock, 2014, Gynecologic oncology.

Molecular characterization of colorectal neoplasia in translational research.

H. Weiss, U. Manne, W. Grizzle, 2001, Archives of pathology & laboratory medicine.

The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.

D. Heimburger, H. Weiss, U. Manne, 2000, Human pathology.

mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON.

H. Weiss, B. Evers, C. Townsend, 2011, American journal of physiology. Cell physiology.

mTORC 1 inhibition increases neurotensin secretion and gene expression through activation of the MEK / ERK / c-Jun pathway in the human endocrine cell line

H. Weiss, B. Evers, C. Townsend, 2011 .

Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer

H. Moseley, Chi Wang, Jinpeng Liu, 2018, Oncotarget.

Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer

H. Weiss, B. Evers, Y. Zaytseva, 2020, Cell Death & Disease.

Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.

W. Mustain, H. Weiss, Eun Y. Lee, 2014, Carcinogenesis.

Prognostic Significance of p27kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage

H. Weiss, U. Manne, W. Grizzle, 2004, Clinical Cancer Research.

Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen independence.

H. Weiss, W. Grizzle, D. Oelschlager, 2001, The Journal of urology.

Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.

Chi Wang, Jinpeng Liu, H. Weiss, 2018, Cancer research.

Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates

Susan G. Hilsenbeck, Heidi L. Weiss, Torsten A. Hopp, 2004, Clinical Cancer Research.

Efficacy of selective estrogen receptor modulators (SERMs) in a murine xenograft model bearing human bladder cancer

G. Sonpavde, H. Weiss, S. Lerner, 2005 .

591: Efficacy of Selective Estrogen Receptor Modulators (SERMS) in a Murine Xenograft Model Bearing Human Bladder Cancer

G. Sonpavde, H. Weiss, S. Lerner, 2005 .

Inhibition of Protein Tyrosine Phosphatase Receptor Type F Suppresses Wnt Signaling in Colorectal Cancer

H. Weiss, B. Evers, Ashley T. Stevens, 2020, Oncogene.

The mitochondrial retrograde signaling regulates Wnt signaling to promote tumorigenesis in colon cancer

Chi Wang, N. Chandel, H. Weiss, 2019, Cell Death & Differentiation.

Regulation of the Potential Marker for Intestinal Cells, Bmi1, by β-Catenin and the Zinc Finger Protein KLF4

H. Weiss, Eun Y. Lee, B. Evers, 2011, The Journal of Biological Chemistry.

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

D. Allred, G. Clark, H. Weiss, 2004, Modern Pathology.

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.

R. Schiff, C. Creighton, C. Osborne, 2008, Cancer research.

Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.

R. Schiff, C. Osborne, H. Weiss, 2007, Journal of the National Cancer Institute.

S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide

Chi Wang, H. Weiss, Lili Liu, 2016, Oncotarget.

Characterization of Promoter Elements Regulating the Expression of the Human Neurotensin/Neuromedin N Gene*

H. Weiss, B. Evers, C. Townsend, 2010, The Journal of Biological Chemistry.

A prognostic model of early breast cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentation

H. Weiss, E. Romond, S. Massarweh, 2012, Breast Cancer Research and Treatment.

De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer

Chi Wang, Jinpeng Liu, H. Weiss, 2018, Molecular Cancer Research.

COVID-19 Test Strategy to Guide Quarantine Interval in University Students

F. Romanelli, R. DiPaola, D. Arnett, 2020, medRxiv.

Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.

W. Mustain, H. Weiss, Eun Y. Lee, 2012, Cancer research.

Role of AMPK and Akt in triple negative breast cancer lung colonization

H. Weiss, Eun Y. Lee, B. Evers, 2021, Neoplasia.

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

S. Hilsenbeck, S. Fuqua, R. Elledge, 2011, Breast Cancer Research and Treatment.

Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer

Heidi L. Weiss, Torsten A. Hopp, Yukun Cui, 2004, Clinical Cancer Research.

Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus.

Zhihua Liu, H. Weiss, Z. Gatalica, 2012, International journal of biochemistry and molecular biology.

Estrogen Receptor Genomic Function Factor Receptor Signaling with Repression of Classic Tamoxifen Resistance in Breast Tumors Is Driven by Growth

R. Schiff, C. Creighton, C. Osborne, 2008 .

Incorporating Protein Dynamics Through Ensemble Docking in Machine Learning Models to Predict Drug Binding

Derek Jones, Xiaofei Zhang, Sally R. Ellingson, 2018, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.

Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression.

D. Heimburger, A. Niveleau, H. Weiss, 2001, Human pathology.

Tu1908 Differential Expression and Tumorigenic Function of Neurotensin Receptor 1 in Neuroendocrine Tumor Cells

H. Weiss, B. Evers, Ji Tae Kim, 2015 .

The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.

D. Heimburger, H. Weiss, U. Manne, 2000, Human pathology.

Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor–positive human breast cancer cells

S. Fuqua, H. Weiss, Yukun Cui, 2006, Molecular Cancer Therapeutics.

Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.

B. Gary, H. Weiss, U. Manne, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.

Chi Wang, H. Weiss, Min Chen, 2016, Human pathology.

The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth

Adrian V. Lee, R. Schiff, C. Osborne, 2006, Breast Cancer Research and Treatment.

Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary

H. Weiss, B. Evers, S. Arnold, 2018, Journal of oncology.

Hazard rates of recurrence following diagnosis of primary breast cancer

S. Hilsenbeck, I. Jatoi, G. Clark, 2004, Breast Cancer Research and Treatment.

Colorectal cancer lung metastasis treatment with polymer–drug nanoparticles

Heather A. Frohman, H. Weiss, Eun Y. Lee, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.

W. Mustain, H. Weiss, Peixuan Guo, 2015, ACS nano.

Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer

Chi Wang, H. Weiss, B. Evers, 2018, Cell Death & Disease.

Loss of PHLPP expression in colon cancer: Role in proliferation and tumorigenesis

H. Weiss, B. Evers, P. Rychahou, 2008, Oncogene.

PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors

H. Weiss, J. Schrader, B. Evers, 2021, Cells.

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer

Adrian V. Lee, Susan G. Hilsenbeck, Carolina Gutierrez, 2010, Breast Cancer Research and Treatment.

Activation of AMPK Stimulates Neurotensin Secretion in Neuroendocrine Cells.

H. Weiss, B. Evers, C. Townsend, 2016, Molecular endocrinology.

Extracellular redox state shift: A novel approach to target prostate cancer invasion

H. Weiss, D. S. St. Clair, W. Zhong, 2018, Free radical biology & medicine.

Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna—A Randomized, Cross-Over Clinical Study

D. Butterfield, R. Sultana, H. Weiss, 2015, PloS one.

Induction of AMPK activation by N,N’-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers

D. Watt, H. Weiss, B. Evers, 2018, bioRxiv.

The Rates of Chemotherapy-Induced Amenorrhea in Patients Treated With Adjuvant Doxorubicin and Cyclophosphamide Followed by a Taxane

R. Elledge, H. Weiss, Y. Tham, 2007, American journal of clinical oncology.

Cotargeting the PI3K and RAS Pathways for the Treatment of Neuroendocrine Tumors

W. Mustain, Chi Wang, H. Weiss, 2014, Clinical Cancer Research.

Cancer Therapy : Preclinical Cotargeting the PI 3 K and RAS Pathways for the Treatment of Neuroendocrine Tumors

W. Mustain, Chi Wang, H. Weiss, 2014 .

Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.

S. Hilsenbeck, C. Osborne, G. Clark, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers

S. Hilsenbeck, Jenny C. Chang, R. Elledge, 2005, Breast Cancer Research and Treatment.

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancer

Jenny C. Chang, R. Elledge, D. Allred, 2005 .

S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2

Mihail I Mitov, D. Butterfield, Chi Wang, 2019, The Journal of Biological Chemistry.

In Vivo Investigation of Hybrid Paclitaxel Nanocrystals with Dual Fluorescent Probes for Cancer Theranostics

H. Weiss, B. Evers, R. Gemeinhart, 2013, Pharmaceutical Research.

Intratumor heterogeneity of biomarker expression in breast carcinomas

H. Weiss, W. Grizzle, W. Grizzle, 2004, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

Progress in Developing Effective Chemoprevention Agents for Cervical Neoplasia

A. Oza, H. Weiss, W. Grizzle, 2005 .

Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.

D. Heimburger, H. Weiss, W. Grizzle, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

MTORC1 and mTORC2 Regulate EMT, Motility and Metastasis of Colorectal Cancer via RHOA and RAC1 Signaling Pathways

H. Weiss, Eun Y. Lee, B. Evers, 2011 .

Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis.

H. Weiss, T. Barrett, Tatiana Goretsky, 2015, Biochimica et biophysica acta.

Everolimus in HR-positive advanced breast cancer.

H. Weiss, S. Massarweh, J. Croley, 2012, New England Journal of Medicine.

Tumor Suppressor Par-4 Regulates Complement Factor C3 and Obesity

B. Taylor, Jinze Liu, O. Melander, 2022, Frontiers in Oncology.

Neurotensin Regulates Proliferation and Stem Cell Function in the Small Intestine in a Nutrient-Dependent Manner

Chi Wang, H. Weiss, B. Evers, 2021, Cellular and molecular gastroenterology and hepatology.

Extracellular vesicle-mediated macrophage activation: An insight into the mechanism of thioredoxin-mediated immune activation

D. Butterfield, H. Weiss, D. S. St. Clair, 2019, Redox biology.

NFATc1 Regulation of TRAIL Expression in Human Intestinal Cells

H. Weiss, Yuning Zhou, B. Evers, 2011, PloS one.

EGFR expression in breast cancer: Association with biologic phenotype, prognosis, and resistance to adjuvant therapy.

R. Elledge, G. Chamness, H. Weiss, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary

H. Weiss, B. Evers, K. Hodges, 2019, Asian Pacific journal of cancer prevention : APJCP.

Signaling and Reduces Metastasis in Colorectal Cancer

W. Mustain, H. Weiss, B. Evers, 2012 .

NFATc 1 Regulation of TRAIL Expression in Human Intestinal Cells

H. Weiss, Yuning Zhou, B. Evers, 2019 .

The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause.

R. Elledge, H. Weiss, Y. Tham, 2006, The journal of supportive oncology.

Fluorinated N,N'-Diarylureas As Novel Therapeutic Agents Against Cancer Stem Cells

H. Weiss, B. Evers, Chunming Liu, 2017, Molecular Cancer Therapeutics.

Use of error grid analysis to evaluate acceptability of a point of care prothrombin time meter.

H. Weiss, J. Petersen, Heidi L Weiss, 2010, Clinica chimica acta; international journal of clinical chemistry.

Receiver Operating Characteristic (ROC) to Determine Cut-Off Points of Biomarkers in Lung Cancer Patients

William E. Grizzle, Heidi L. Weiss, H. Weiss, 2004, Disease markers.

TSC2/mTORC1 signaling controls Paneth and goblet cell differentiation in the intestinal epithelium

H. Weiss, Yuning Zhou, B. Evers, 2015, Cell Death and Disease.

Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIα for anthracycline chemotherapy in locally advanced breast cancer

R. Elledge, H. Weiss, G. Arpino, 2005, Breast Cancer Research and Treatment.

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

D. Allred, G. Clark, H. Weiss, 2005, Modern Pathology.

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

Jenny C. Chang, W. Qian, H. Weiss, 2015, Breast Cancer Research.

Effects of acute and chronic body weight gain reductions in the evaluation of agents for efficacy in mammary cancer prevention.

V. Steele, G. Kelloff, H. Weiss, 2001, Oncology reports.

Effects of Body Weight Gain Reduction Resulting From Chemopreventive Agent Treatment on Mammary Gland Morphology

V. Steele, H. Weiss, W. Grizzle, 2002, Nutrition and cancer.

The mitochondrial retrograde signaling regulates Wnt signaling to promote tumorigenesis in colon cancer

Chi Wang, N. Chandel, H. Weiss, 2019, Cell Death & Differentiation.

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

R. Schiff, R. Elledge, C. Osborne, 2005, Journal of the National Cancer Institute.